Statistics for CRISPR Therapeutics AG (id:6407 CRSP)

Valuation metrics

Market cap

4.04B

Enterprise value

2.32B

Trailing P/E (ttm)

-24.36

Forward P/E

-9.38

PEG ratio

-9.38

Price/Sales (ttm)

19.90

Price/Book (mrq)

2.08

Enterprise Value/Revenue

11.46

Enterprise Value/EBITDA

-7.43

Overview

Shares outstanding

85.35M

Float

83.90M

Shares short

18.59M

% Held by insiders

0.02%

% Held by institutions

0.72%

Average volume (10 days)

2.20M

Average volume (90 days)

Price summary

52-Week low

43.42

52-Week high

91.10

52-Week change

-49.15%

Beta

1.66

50-Day moving average

47.88

200-Day moving average

57.52

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-118.13%

Operating margin

-18,294.02%

Operational effectiveness

Return on assets

-9.57%

Return on equity

-13.07%

Income statement

Revenue (ttm)

2.45

Revenue per share (ttm)

2.45

Quarterly revenue growth (yoy)

Gross profit (ttm)

239.75M

EBITDA

-313,078,016.00

Net income to common (ttm)

-239,594,000.00

Diluted EPS (ttm)

-2.79

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.94B

Total cash per share (mrq)

22.68

Total debt (mrq)

227.54M

Total Debt/Equity (mrq)

11.73

Current ratio (mrq)

2.16K%

Book value per share (mrq)

22.73

Cash flow

Cash flow statement

-188,816,000.00

Levered free cash flow (LFCF)

-118,566,872.00